LRRK2 and Alzheimer disease: On the one hand, the first hint about this potential link was suggested more than a decade ago, but the analysis of 754 patients who meet the Stroke–AD and Related Disorders Association and National Institute of Neurological and Communicative Disorders criteria for AD, did not have the G2019S LRRK2 mutation [47].